Voraxaze for Delayed Methotrexate Clearance

Clinical trial NCT00424645 · TERMINATED

Trial details

NCT number: NCT00424645
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancy Solid Tumor

Start date: 2007-01-01
Primary completion: 2008-01-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.